A.I.O.
This Week In Medicine
Welcome to This Week in Medicine - Your Filtered Medical Journal SummaryLooking to stay up-to-date with the latest medical research but short on time? This Week in Medicine has you covered! Our AI generated podcast provides you with a convenient, on-the-go solution to keep you informed about the most significant developments in the medicine field. We understand that your time is valuable, so we've done the hard work for you. Each episode offers a filtered and concentrated summary of key journal articles, allowing you to stay informed without the need to sift through pages of research papers. W...
Vizitează neapărat site-ul podcastului și susține-i creatorul: redcircle.com
Unde asculți?
Podcasturi în aplicație Replaio Radio În curândPodcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor
Episoade
NEJM November 5, 2026 Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis 05.11.2026 1:16
Recent clinical research evaluated the effectiveness of plozasiran, an innovative RNA-based therapy, in treating individuals diagnosed with severe hypertriglyceridemia. Across two closely monitored trials involving 757 participants, patients received either the targeted medication or a placebo to measure changes in fasting lipid levels over a one-year period. The findings revealed that administrat...
NEJM November 5, 2026 Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain 05.11.2026 1:35
A recent clinical trial investigated whether performing computed tomographic (CT) coronary angiography could lower the long-term risk of heart-related complications in emergency department patients whose heart attacks were initially excluded. Researchers across the United Kingdom monitored over 3,100 intermediate-risk participants who were randomly split to receive either specialized CT imaging or...
NEJM November 5 , 20026 Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity 05.11.2026 1:46
A recent clinical trial investigated the effectiveness of retatrutide, an innovative triple-hormone receptor agonist, for managing obesity in adults. Over an eighty-week period, participants received weekly injections of the medication or a placebo to measure changes in body weight, knee osteoarthritis pain, and obstructive sleep apnea severity. The findings revealed that individuals treated with...
JAMA October 2026 Risk-Based vs Annual Breast Cancer Screening The WISDOM Randomized Clinical Trial 29.10.2026 1:57
A large-scale clinical trial involving more than 28,000 women was conducted to evaluate whether risk-based breast cancer screening serves as a viable substitute for traditional annual mammography. By utilizing genetic testing, polygenic risk scores, and clinical models, participants in the experimental group were assigned customized screening schedules tailored to their specific vulnerability leve...
JAMA October 2026 Trastuzumab Rezetecan in ERBB2-Low Advanced Breast Cancer The HORIZON-Breast06 Randomized Clinical Trial 29.10.2026 1:35
The HORIZON-Breast06 clinical trial investigated the effectiveness of trastuzumab rezetecan compared to standard chemotherapy for individuals suffering from ERBB2-low advanced breast cancer. Conducted across numerous medical centers in China, the multi-center study randomly divided 551 eligible participants into two distinct treatment groups. The primary focus of the research was to measure progre...
NEJM Oct 22 2026 Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis 28.10.2026 1:39
A recent international clinical trial investigated whether shortening antibiotic regimens for left-sided infective endocarditis is safe and effective once patients achieve clinical stability. Researchers compared a response-tailored strategy—which stopped antibiotics earlier—against the standard six-week duration across more than 500 participants. The findings revealed that the tailored approachsu...
NEJM Oct 22 2026 Ianalumab for the Treatment of Patients with Sjögren’s Disease 28.10.2026 1:45
Two clinical studies, NEPTUNUS-1 and NEPTUNUS-2, evaluated the effectiveness of the antibody ianalumab as a potential medical intervention for Sjögren's disease, a complicated autoimmune condition lacking specialized treatments. Researchers divided hundreds of participants into groups to compare monthly or quarterly subcutaneous injections of the medication against a placebo over the course of...
NEJM Oct 22 2026 Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event 28.10.2026 1:41
A recent clinical trial investigated whether the medication milvexian could safely lower the chances of secondary heart attacks and strokes in individuals recovering from acute coronary syndrome. Researchers administered either milvexian or a placebo alongside standard antiplatelet treatments to over fourteen thousand participants in this global study. Ultimately, the investigation was halted earl...
JAMA October 2026 Out-of-Pocket Costs for Chronic Illness Management in High-Deductible Health Plans 13.10.2026 1:32
A recent retrospective study examined out-of-pocket expenses for working-age adults managing common chronic conditions like diabetes and hypertension. Researchers analyzed national commercial insurance claims from 2022 to 2023 to compare financial burdens between high-deductible health plans and traditional coverage. The findings revealed that patients enrolled in high-deductible policiesfaced ann...
JAMA October 2026 Patient Navigation Plus mHealth Incentives for Linkage to OUD Care for Adults Who Also Use Methamphetamines A Pilot Randomized Clinical Trial 13.10.2026 1:28
This clinical trial investigated a mobile health strategy combined with patient navigation to improve outpatient care for hospitalized adults struggling with both opioid use disorder and methamphetamine use. Researchers randomly assigned participants to receive either standard treatment or an intervention featuring financial rewards for medication adherence and dedicated support during the first m...
JAMA October 2026 Digital and Coaching Interventions for Uptake of Cancer Genetic Testing The MiGHT Randomized Clinical Trial 13.10.2026 1:32
The Michigan Genetic Hereditary Testing trial explored how to increase low completion rates for hereditary cancer genetic testing. Researchers evaluated nearly eight hundred adult participants who qualified for genetic evaluation across three different groups. Individuals were randomly assigned to receive either telephone-based health coaching, a self-directed digital tool, or standard care. The f...
JAMA Cardiology October 2026 Global, Regional, and National Burden of Heart Failure, 1990-2023 A Systematic Analysis for the Global Burden of Disease Study 2023 12.10.2026 1:33
A recent cross-sectional analysis utilizing Global Burden of Disease methodologies evaluates the worldwide impact and underlying causes of heart failure across 204 countries and territories from 1990 to 2023. By synthesizing extensive data, the research revealed an estimated 56.0 million cases globally in 2023, with prevalence rates consistently rising alongside advancing age. The study highlights...
JAMA Cardiology October 2026 Intensive vs Standard Blood Pressure Lowering in People With and Without Chronic Kidney Disease 12.10.2026 1:29
recent systematic review and meta-analysis investigated how aggressively reducing blood pressure impacts heart health and renal function in adults. By examining twenty-seven randomized trials encompassing nearly ninety thousand participants, researchers compared intensive and standard blood pressure management strategies. The findings revealed that aggressive blood pressure reduction significantl...
JAMA October 2026 Development and Validation of an Adult Medical Urgency Score for US Donor Heart Allocation 12.10.2026 1:31
A recent observational study utilized registry data from adult heart transplant candidates to create and validate the US Candidate Risk Score (US-CRS) as a replacement for the current six-status allocation framework. This new quantitative model relies on specific laboratory values and mechanical support devices to more accurately assess a patient's risk of mortality while waiting for an organ....
JAMA October 2026 Advance Care Planning for Black and White Older Adults With Serious Illness The EQUAL ACP Randomized Trial 09.10.2026 1:27
The EQUAL ACP randomized trial investigated whether facilitated advance care planning outperforms self-guided methods for seriously ill older adults. Researchers evaluated completion rates over one year among nearly eight hundred Black and White participants aged sixty-five and older across multiple Southern clinics. Overall results indicated no statistically significant difference in completion b...
JAMA October 2026 Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease The NOPARK Randomized Clinical Trial 09.10.2026 1:41
A recent phase 3 clinical trial investigated whether the supplement nicotinamide riboside could slow the progression of early-stage Parkinson disease. Researchers across eleven centers in Norway administered either the substance or a placebo to 393 participants over a 52-week period. To measure disease severity, the study tracked changes using standard movement and non-motor symptom scales. Ultima...
NEJM 10 8 2026 Vasopressors or Fluids in Early Septic Shock 09.10.2026 1:36
Vasopressors or Fluids in Early Septic Shock
NEJM 10 8 2026 Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis 09.10.2026 1:34
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
NEJM 10 8 2026 Tricuspid-Valve Intervention in Heart Failure 09.10.2026 1:32
Researchers conducted a clinical trial to determine whether transcatheter tricuspid-valve repair could improve health outcomes for older adults suffering from severe tricuspid regurgitation and heart failure risks. Participants were randomly divided to receive either the combined procedure with medical treatment or standard medication alone. At the one-year mark, the evaluation showed significantl...
NEJM 10 1 2026 Giredestrant plus Everolimus in Advanced Breast Cancer 07.10.2026 1:46
Giredestrant plus Everolimus in Advanced Breast Cancer
NEJM 10 1 2026 Obexelimab for the Treatment of IgG4-Related Disease 07.10.2026 1:29
A recent phase 3 clinical trial investigated obexelimab, a novel monoclonal antibody that suppresses B-cell function without destroying the cells, as a potential therapy for IgG4-related disease. Standard treatments typically rely on glucocorticoids, which often cause significant toxicity and frequently lead to relapses once stopped. To test the medication, 194 patients were randomly assigned to r...
NEJM 10 1 2026 Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults 07.10.2026 1:36
Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults
JAMA 9 2026Intrauterine Mepivacaine Instillation vs Placebo for Pain During IUD Placement A Randomized Clinical Trial 24.09.2026 1:24
This clinical study investigates whether applying a local anesthetic directly into the uterus can alleviate the discomfort typically associated with IUD insertion for women who have never given birth. By comparing the effects of mepivacaine against a saltwater placebo, researchers discovered that the medication significantly lowered pain scores and improved the overall tolerability of the procedur...
JAMA 9 2026 Medicare Advantage Enrollment and Access to Kidney Transplant After the 21st Century Cures Act 24.09.2026 1:43
This retrospective study evaluates whether the expansion of Medicare Advantage eligibility for patients with end-stage kidney disease has impacted their ability to receive life-saving treatments. By comparing data from 2021 through 2023, researchers discovered that those enrolled in private Medicare Advantage plans faced significantly lower rates of kidney transplantation and new wait-listing comp...
JAMA 9 2026 Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion The ATTENTION LATE Randomized Clinical Trial 24.09.2026 1:39
This clinical study investigated whether administering the clot-busting drug tenecteplase prior to a surgical thrombectomy would benefit patients experiencing a severe stroke in the back of the brain. Researchers focused specifically on individuals who arrived at the hospital in a late time window, between 4.5 and 24 hours after their symptoms began. The trial discovered that adding the medication...
Podcasturi asemănătoare
Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice